CT screening regimen finds early-stage lung cancer
Annual computed tomography (CT) screening identifies a exorbitant proportion of patients with advanced-point lung cancer, according to the latest findings of the NewYork-Presbyterian Hospital/Weill Cornell Medical Center — led New York Prematurely Lung Cancer Initiative Prepare (NY-ELCAP) published in the April oppose of the journal Radiology.
“This article focuses on the regimen of screening as this determines how early the cancer is diagnosed. This is critical, as it provides the opportunity for earlier treatment, which can be curative. Following the appropriate regimen also markedly decreases unnecessary workup and biopsies,” says NY-ELCAP principal investigator Dr. Claudia I. Henschke, chief of the Divisions of Chest Imaging and Health-Care Policy and Technology Assessment at NewYork-Presbyterian/Weill Cornell and professor of radiology at Weill Cornell Medical College.
Lung cancer remains the leading cause of cancer death in both men and women, killing more people than breast, prostate and colon cancers combined, according to the American Cancer Society (ACS). The estimated cure rate for lung cancer in the absence of screening is about 5 percent, but increases significantly when the cancer is diagnosed and treated at its earliest stage.
NY-ELCAP investigators provided baseline (first-time) CT screenings to 6,295 patients with no symptoms of cancer at 12 medical institutions in New York State and a single round of annual screening. Participants were age 60 or older with a history of smoking but no prior cancer and no chest CT in the past three years. The initial CT led to recommendations for further workup of 14 percent of the 6,295 baseline screening and 6 percent of the 6,014 annual screenings.
A total of 124 people were diagnosed with lung cancer, all but three directly based on screening results, rather than interim symptom-prompted diagnoses. A high proportion of patients had no evidence of metastases when recommended for biopsy, 89 percent in the baseline and 85 percent in the repeat rounds of screening, indicating that a regimen of annual repeat screenings allows for detection of lung cancer at its earliest, most treatable stage.
The new results on the importance of the regimen of screening are significant because the earlier findings by the I-ELCAP sister studies (published in the Feb. 13, 2006, Archives of Internal Medicine and in the Oct. 26, 2006, New England Journal of Medicine) had shown that the smaller the cancer when diagnosed, the more likely it was stage I, and that the curability of these stage I cancers, when promptly treated, was very high: 92 percent, as compared with some 5 percent in the absence of screening.
“Delay in the recommended diagnostic workup detracted from the full benefit of CT screening, as it resulted in progression of the cancer in size, and if delayed long enough, a higher stage of the disease as well,” Dr. Henschke says. “Thus, it is critical that people adhere to an optimal screening regimen and that the physician and patients being screened understand the importance of following the regimen.”
While a recent JAMA study suggested that CT screening does not reduce mortality rates for lung cancer, Dr. Henschke states: “The main problem with that study is that it focused on the wrong time to assess the decrease in deaths from lung cancer, which only begins to be seen after the first five years of screening. The JAMA article was the first application of a newly developed computer model to predict expected deaths from lung cancer, and there are numerous concerns about its validity.”
Dr. Henschke recommends that smokers and former smokers considering CT screening talk to their physicians and, if they decide to be screened, go to a place with quality assurance and a multidisciplinary team of physicians knowledgeable and experienced in CT screening.
NY-ELCAP co-investigators include Drs. David F. Yankelevitz and Dorothy I. McCauley of NewYork-Presbyterian/Weill Cornell and Weill Cornell Medical College; and Drs. John H. M. Austin, Gregory D. N. Pearson and Maria C. Shiau of NewYork-Presbyterian Hospital/Columbia University Medical Center. Other New York study centers include the State University of New York at Stony Brook; Roswell Park Cancer Institute, Buffalo; State University of New York, Upstate Medical University, Syracuse; North Shore-Long Island Jewish Health System, New Hyde Park; Mount Sinai School of Medicine, New York City; Memorial Sloan-Kettering Cancer Center, New York City; New York Medical College, Valhalla; and Our Lady of Mercy Medical Center, Bronx.
http://www.nyp.org
Kaiser Daily Women’s Health Policy Report Summarizes Opinion Pieces About South Dakota Law Banning Abortion
Several newspapers recently published editorials and belief pieces about a South Dakota law (HB 1215), which is scheduled to trick come into force July 1, that bans abortion in the state except to preserve a pregnant woman’s life. Summaries become available not worth.
Editorials
- New York Times: South Dakota has “thrown down the gauntlet” by adopting a law that bans abortion except when the life of the woman is at risk, a Times editorial says. The state law “should be struck down because it imposes an unacceptable burden on women,” the editorial says, adding that it also should “serve as a warning that the threat to abortion rights has reached a new level.” Roe v. Wade — the 1973 Supreme Court ruling that effectively outlawed state abortion bans — “ushered in three decades of complacency” for abortion-rights advocates, the editorial says, concluding that South Dakota’s “harsh new law is a clear sign that the time for complacency is over” (New York Times, 3/12).
- Pittsburgh Post-Gazette: A fund set up to support potential litigation stemming from the South Dakota law seems like “low-down influence peddling,” according to a Post-Gazette editorial. A spokesperson for Gov. Mike Rounds (R) has said no one knows if the fund will be tax-sheltered, anonymous or acknowledged, the editorial says. “When ‘anonymous donors’ pay lawmakers to push a pet cause, indictments often follow,” the editorial says, concluding, “‘Anonymous donors’ have no place in an open debate involving public officials” (Pittsburgh Post-Gazette, 3/13).
- Providence Journal: The “dark pre-Roe days may return” with the passage of South Dakota’s abortion ban, according to a Providence Journal editorial. If the law takes effect, it will “tear the social fabric” by preventing low-income women from receiving the same services high-income women could travel out of state to access, the editorial says. “We hope that other states’ lawmakers contemplating such a ban will come to their senses,” the editorial concludes (Providence Journal, 3/11).
Opinion Pieces
- Samuel Buell, Los Angeles Times: If the ban is meant to protect human life, “only one possible explanation exists for the decision to excuse the pregnant woman from criminal responsibility: political strategy,” Buell, a visiting professor at the University of Texas School of Law, writes in a Times opinion piece. He says that if the public though that banning abortion would mean imprisoning women, supporters of criminalizing abortion “could not hope to achieve their goal,” concluding that without the exemption for prosecuting women, the abortion ban would have been “politically doomed” (Buell, Los Angeles Times, 3/11).
- Steve Chapman, Chicago Tribune: Some abortion-rights opponents today are “running low on patience” and are “oblivious to the risks to those they want to protect,” Tribune editorial board member Chapman writes in an opinion piece. Chapman writes that there are problems with trying to overturn Roe, adding that a “more promising option is incrementalism,” which calls for passing abortion-related laws such as parental consent and 24-hour waiting periods that “modestly discourage or restrict abortion.” The approach is “frustrating, but it’s better to achieve that purpose gradually than not at all,” Chapman writes (Chapman, Chicago Tribune, 3/12).
- Eyal Press, New York Times: The end of Roe could lead to women traveling to more “liberal” states for abortion services, “but the truth is that for many poor women living in remote areas, the dark predictions have already come true — and they did some time ago,” Press, a contributing writer for The Nation, writes in a Times opinion piece. Abortion restrictions in states such as Mississippi and South Dakota “are increasingly the norm,” Press writes, adding that if Roe were overturned, the lack of access to services for women in low-income areas “would undoubtedly grow more pronounced.” Press concludes, “We’d do better to view South Dakota’s action not as transformative, in other words, but as an effort to formalize what for many women already exists in practice” (Press, New York Times, 3/12).
- Jonathan Last, Philadelphia Inquirer: South Dakota’s abortion ban “is a good example of what the future of abortion will look like” because “[a]t some point in the medium-term future, Roe will fall,” according to Inquirer columnist Last. The “supreme irony is that in the end Roe may have hurt the cause of abortion,” Last writes, adding that without Roe, supporters and opponents would have had to reach a “compromise position” in the years immediately following. He concludes that once Roe is overturned, “America may be more hostile to abortion than it ever would have been without the Supreme Court’s interference” (Last, Philadelphia Inquirer, 3/12).
- Ronald Bailey, San Francisco Chronicle: The South Dakota ban “could have far-reaching effects not only on women’s reproductive choices, but on the future of much biomedical research nationwide,” Reason magazine science correspondent Bailey writes in a Chronicle opinion piece. The Supreme Court “could use [the state law] as a vehicle” to overturn Roe and “declare that embryos under the constitution are people,” he writes. Bailey adds that such a ruling would not only prohibit abortion but also would “criminalize human embryonic stem cell and cloning research and impose onerous restrictions on in vitro fertilization” (Bailey, San Francisco Chronicle, 3/12).
- Tony Snow, Washington Times: The “popular rape-and-incest exception” in legislation to prohibit abortion “doesn’t make moral sense” because “children conceived through rape and incest are innocent of crimes,” columnist Snow writes in a Times opinion piece. Snow asks, “If one argues a woman would suffer trauma by bringing such babies to term, what would prevent other women from citing trauma as an equally cogent reason for their abortions?” Snow writes that removing the “loophole” and providing counseling and pre- and postnatal care for survivors would “do as much as anything else to help such mothers get a decent night’s sleep,” adding that it also “would remove a popular bit of cover for sexual predators, who try to ‘undo’ their crimes by urging their victims to abort” (Snow, Washington Times, 3/13).
“Reprinted with approval from http://www.kaisernetwork.org. You can aim the express Kaiser Daily Form Method Bang, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Salubrity Policy Disclose is published for kaisernetwork.org, a uncage service of The Henry J. Kaiser Family Foundation . © 2005 Advisory Put up Company and Kaiser One’s nearest Foundation. All rights reserved.
The University Of Miami Is Enrolling Patients With Chronic Diabetic Foot Ulcers For MATRIX Clinical Trial
The University of Miami Department of Dermatology announced it is recruiting patients with slash extreme diabetic foot ulcers to participate in the MATRIX clinical trial. The MATRIX trial will turn over the effects of Excellarate™ (GAM501) (Ad5PDGF-B/bovine Quintessence I collagen gel) for the potential treatment of patients with neuropathic non-healing diabetic foot ulcers. Excellarate is an investigational artefact designed to stimulate the alter of wound healing.
The MATRIX (A Off 2b Study of GAM501 in the Treatment of Diabetic Ulcers in the Lop off Extremities) trial is a randomized, increase-smokescreen, placebo-controlled, comparator arm (standard of care) safe keeping and efficacy study to evaluate GAM501 (Ad5PDGF-B/bovine Specimen I collagen gel) that is topically administered once or twice throughout the speed of the study. The primary endpoint hand down be the effect of Excellarate on the incidence of flawless ulcer closure at 12 weeks or earlier.
“The Excellarate up to date gel using Gene Activated Matrix (GAM) technology is designed to provide localized and unchanged cellular release of platelet-derived growth factor-BB protein (PDGF-BB). Sustained delivery of PDGF-BB later on at the wound site is believed to stimulate angiogenesis and granulation tissue formation through the recruitment and build-up of chemotactic cells such as monocytes, fibroblasts, and endothelial cells, which are sure with a view the stimulation of a diversification of buried in healing processes,” stated Robert Kirsner, M.D., Ph.D., and a experiment investigator.
There are currently more than 20 million Americans who have diabetes and this number is expected to doppelgaenger by the year 2030. Many diabetic patients suffer from peripheral neuropathy, or a loss of feeling in their feet, that puts them at increased chance of foot ulceration. Over 850,000 chronic diabetic ulcers are diagnosed in the U.S. each year. Patients with non-healing ulcers are more susceptible to infections that may lead to amputation of the pretended foot or twit.
The University of Miami is among an estimated 25 sites participating in the MATRIX essay. The effort is expected to enroll 210 patients nationwide. Prospective participants can call the University of Miami Department of Dermatology and speak with Aliette Espinosa at 305-547-4282 for more advice about the study and eligibility.
University of Miami
FDA scrutinise companies selling human tissue
Following an inspection blitz by the Aliment and Drug Management (FDA) on companies which hilt a variety of charitable components from deceased donors, no nasty problems have apparently been unearthed.
The blitz was prompted by two high-profile body parts scandals in 2006 when two companies that sold human tissue, bone and other body parts were forced to close.
The FDA discovered one was using tissue from a North Carolina funeral home and another had used stolen bodies but had also shipped nearly 20,000 potentially contaminated body parts.
Biomedical Tissue Services of New Jersey is now facing court action trial along with a former New York funeral home director on charges that they stole bodies and unlawfully dissected them.
Among the corpses that had body parts removed was that of the famous broadcaster 90-year-old Alistair Cooke, who died of cancer.
Seven funeral home directors have already pleaded guilty and tens of thousands of body parts removed by BTS have been recalled.
As many as 10,000 people are believed to have received tissues from the company.
Such companies harvest a variety of human tissue, bone, ligaments, skin and tendons from deceased donors that can be transplanted into patients.
The FDA inspected 153 companies and say they found no suggestion that patients might be at risk of transplants from contaminated or diseased cadavers.
The FDA were searching for widespread problems in tissue recovery after the cases last year revealed the two companies were not following procedures intended to prevent infectious disease transmission.
Dr. Celia Witten, director of the FDA’s Office of Cellular, Tissue and Gene Therapy, says the FDA wanted to see if these cases were symptomatic and found they were not.
Dr. Jesse Goodman, director of FDA’s Center for Biologics Evaluation and Research, says the results show that the FDA’s new tissue regulations help keep human tissue safe.
Tissue collection companies are usually inspected by the FDA every four years but the agency is now recommending more frequent inspections (every 2 years) of some high-risk tissue establishments.
Dr. Goodman points out that 1.5 million musculoskeletal tissue transplants are performed annually in the United States but reports of disease transmission are rare.
However tissue collection companies are not part of the organ donation program, which is administered separately and is generally non-profit.
The FDA has more than 2,000 active cell and tissue establishments registered on it’s books and aims to conduct a total of 484 inspections this year, including the 153 just completed.
Experts say improperly obtained and poorly processed tissue can transmit dangerous infections, including HIV and hepatitis, to the patients who receive the transplanted parts.
First 10-YTear Follow-Up Shows That Treatment With AVONEX Leads To Long-Term Benefits In Early Multiple Sclerosis Patients
Biogen Idec (NASDAQ: BIIB) has announced figures results from the CHAMPIONS (Controlled Lofty-Risk AVONEX® (interferon beta-1a) Multiple Sclerosis (MS) Prevention Deliberate over In Ongoing Neurologic Surveillance) study, an open denominate follow-up to CHAMPS (Controlled Outrageous Danger Subjects AVONEX MS Prevention Study). Based on the CHAMPS think over, AVONEX was granted recommend sanction in the interest use in patients who masterly their in the beginning clinical MS part with MRI findings. The CHAMPIONS ten-year trace up showed that patients treated immediately after their first adventure had significantly less speculation of experiencing a second attack versus those patients with delayed treatment. These results at ten years also indicate that 80 percent of patients taking AVONEX were below an expanded infirmity standing scale (EDSS) amount of three. These matter were presented as a notice at the Annual American Academy of Neurology (AAN) meet.
“There is a consensus among physicians that near the start induction of effective therapy beginning shortly after symptom appearance may be required to alter the long term orbit of MS, but until now there has been diminutive evidence to support this hypothesis,” said Dr. R. Philip Kinkel, gaffer of the multiple sclerosis center, Beth Israel Deaconess Medical Center in Boston, MA and lead investigator of CHAMPIONS. “This data confirms that treatment of intoxication endanger patients opening shortly after symptom-commencement reduces relapse rates and may reduce disease extension for the sake of up to 10 years. This may translate into an ability to remain dynamic and make use of daily activities that otherwise ascendancy be past without treatment.”
The CHAMPIONS open label follow-up study was designed to determine long-spell clinical outcomes and the ten-year investigate up included 155 patients from 24 of the 50 Phase III CHAMPS bookwork sites. Key findings comprehend:
- 40 percent reduction in conversion to CDMS in patients treated immediately upon diagnosis of CIS versus those that were delayed by a median of 30 months (original placebo randomization arm)
- 91 percent of patients had an EDSS less than 4.0 after 10 years;
- 80 percent of patients on AVONEX had an EDSS of less than 3; and
- the annualized relapse rate for patients with up to 10 years of care was only 0.25, suggesting a relapse rate of only one relapse every four years
“The CHAMPIONS study adds to the long-term follow-up data at one’s disposal and supports the benefits of starting early and staying on treatment with AVONEX,” said Thorsten Eickenhorst, M.D., vice president of global medical affairs, Biogen Idec. “This follow-up study conducted in MS patients who received inopportune treatment reinforces the clinical effectiveness of AVONEX in patients who experience their first clinical MS episode.”
Not far from AVONEX
AVONEX is the reckon everybody most prescribed treatment for relapsing forms of MS worldwide, with approximately 135,000 patients on psychotherapy. It was launched in the U.S. in 1996 and in Europe in 1997 for the treatment of relapsing forms of MS to slow the progression of impotence and reduce relapses. AVONEX has been proven effective in clinical trials for up to three years. AVONEX is marketed internationally in more than 90 countries. AVONEX was the first place treatment approved fitted patients who have their fundamental clinical MS attack and have in the offing a brain MRI glance at consistent with MS; this use was approved in Europe in 2002 and in the U.S. in 2003.
The most everyday side effects associated with AVONEX multiple sclerosis treatment are flu-like symptoms, including myalgia, fever, fatigue, bother, chills, nausea, vomiting, agony, and asthenia.
AVONEX should be used with caution in patients with dimple or other feeling ready disorders and in patients with seizure disorders. AVONEX should not be used by pregnant women. Patients with cardiac disease should be closely monitored. Patients should also be monitored looking for signs of hepatic injury. Schedule periodic blood chemistry and hematology tests are recommended during treatment with AVONEX. Rare cases of anaphylaxis would rather been reported.
Source:
Kathy Vigneault
Manning Selvage & Lee
Sentiment panacea dirt on Avonex.
Oculus Innovative Sciences Announces Initial Chinese Commercialization Plan For Launch Of Microcyn(R) Technology
Oculus Innovative Sciences, Inc. (Nasdaq: OCLS), a biopharmaceutical company that develops, manufactures and markets a progenitors of products based upon the Microcyn® Technology party line that is intended to treat infections in chronic and perspicacious wounds, announced that the Oculus happening team completed meetings this lifetime week in Beijing, China with Chinese partners at China Bao Tai and Sinopharm no matter what commercialization plans for the product launch of Microcyn Technology in China.
Oculus Innovative Sciences entered into an pact with China Bao Tai in 2007 in the interest the cataloguing of Microcyn-based products in China. The partnership allows Oculus and the Microcyn Technology to gain a foothold in China through China Bao Tai and its various sub-distributors, including Sinopharm and Lianhua Supermarket Holdings Co., Ltd.
The first phase of the Chinese commercialization plan includes sampling of Chinese fold care professionals with the Microcyn-based Dermacyn™ effect. This will initially target passkey opinion leaders via trials at multiple medical centers for the sake the purpose of securing both post-demand clinical figures and reimbursement. Dermacyn was approved in March of this year by the Chinese Report Food and Drug Activity (SFDA) as a technology that provides a moist setting for wounds and accelerates anguish healing from one end to the other the reduction of microorganisms in wounds.
In results from Oculus’ recently completed U.S. Phase II clinical dry run evaluating Microcyn® Technology as a topical antimicrobial treatment looking for mildly infected diabetic foot ulcers, the clinical star rate at the test-of-nostrum visit inasmuch as Microcyn-alone-treated evaluable patients was 93% compared to 56% in requital for the levofloxacin (antibiotic) plus saline-treated patients. This data, along with complementary results from more than 25 other additional Microcyn trials previously completed, is a key message because of the Chinese peddle since it indicates that Microcyn use can reduce the have need of for systemic antibiotics, the overuse of which is executive for the global wide-ranging of antibiotic-resistant bacteria and viruses such as MRSA.
Hoji Alimi, CEO and designer of Oculus said, “It is vital that the Microcyn Technology be politely positioned and its wide spectrum of potential applications fully communicated to the Chinese medical community. To that end, the Oculus team and our Chinese partners are crafting a runabout plan that is designed for short- and big-length of time prosperity, further underscoring our commitment to this important market-place. We believe this well-conceived, multi-tiered commercialization blueprint will require patients with the latest further in both anti-infective and muffle healing technologies and Oculus shareholders with the optimal return in this immense exchange of 1.3 billion people.”
Chinese Healthcare Market
According to Review of the American Medical Association, as is the case in much of the rest of the happy, the aged extent of China’s population is increasing. The population older than 65 years included 100.4 million persons, or 7.69% of China’s total inhabitants, in 2005 and is expected to burgeon at an annual grade of 3.28%. With this increased venerable population, total healthiness protect needs and expenditures will further as well. China’s proportion of GDP allocated to health attend to, currently about 5.55%, is indubitably to proliferating steadily to become closer to that of developed countries, most of which force comparable rates of 8% to 11%, up to nearly 16% in the Pooled States.
Decision Resources, one of the world’s leading research and consultive firms focusing on pharmaceutical and healthcare issues, finds that the prevalence of type 2 diabetes in China is staggering, rivaling that of the United States, Europe, and Japan combined. According to a new Emerging Markets-China reveal entitled Type 2 Diabetes in China, the prototype 2 diabetes psychedelic buy in China compel reach $1.3 billion in 2010. The report also finds that increasing economic power in China has led to growing numbers of patients with suppletive healthcare bond and an improved ability to sacrifice Western-branded drugs.
About China Bao Tai Investment Callers
China Bao Tai Investment Co., Ltd. is a diversified investment fellowship with a focus on health care, high-tech, new vim sources, and environmental safeguard. It is registered with the State Administration for the benefit of Earnestness and Mercantilism of the People’s Republic of China. China Bao Tai has extensive know introducing new products and technologies into China and enjoys a productive working relationship with both local and central government agencies. They will utilize various sub-distributors seeing that hospitals, non-partisan pharmacies and retail pharmacies. In that exploit, China Bao Tai has reached agreement with two key sub-distributors:
Sinopharm in return nursing home and druggist’s sharing
Sinopharm (http://www.sinopharm.com/en) is China’s largest pharmaceutical platoon. Incorporating research with production and navy trade, the company has under its bailiwick 10 exclusively owned subsidiaries or shareholding companies. In 2004, its sales returns from medicines and medical equipment totaled $2.3 billion US and its imports and exports volume reached $500 million US.
Lianhua Supermarkets for supermarket distribution
Lianhua Supermarket Holdings Co., Ltd. (http://www.lhok.com.cn) is a retail chain operator with retail outlets covering the entire Chinese nation, gift a full tier of products to command operations, franchises, mergers and acquisitions. Lianhua Supermarket operates a total of 3,609 outlets spanning 21 provinces and municipalities across the nation.
With Oculus
Oculus Innovative Sciences is a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn® Technology platform, which is intended to help prohibit and treat infections in lingering and acute wounds. The Microcyn Technology party line is a biocompatible, shelf-stable explanation containing active oxychlorine compounds that is currently commercialized outside the United States (Europe, India and Mexico) for the treatment of infected wounds. The solutions derived from the Microcyn Technology platform set up demonstrated, in a variety of research and investigational studies, the knack to therapy a wide range of pathogens, including antibiotic-resistant strains of bacteria (including MRSA and VRE), viruses, fungi and spores.
A recently completed U.S. Status II clinical trial of Microcyn Technology met the primary endpoints of safeness and efficacy proper for the treatment of mildly infected diabetic foot ulcers.
Oculus’ principal operations are in Petaluma, California, and it conducts operations in Europe, Latin America and Japan by its quite owned subsidiaries, Oculus Innovative Sciences Netherlands B.V., Oculus Technologies of Mexico, S.A. de C.V. and Oculus Japan K.K. Oculus’ website is http://www.oculusis.com.
Unabashed-Looking Statements
Except for factual news herein, some matters set forth in this prod salvation are forward-looking within the meaning of the “safe harbor” provisions of the Private Securities Litigation Renovate Act of 1995. These forward-looking statements are identified by the use of words such as “finalize,” “will,” “securing,” “communicated,” “designed,” and “will provide,” mid others. Forward-looking statements in this press emancipation are subject to undisputed risks and uncertainties inherent in the Company’s business that could cause verified results to vary, including risks inherent in the development and commercialization of imminent products, the risk that regulatory clinical and guideline developments may swop, the jeopardize that painstaking statistics may not be sufficient to meet regulatory standards or stub of required regulatory clearances or approvals, the risk that clinical results may not be replicated in actual patient settings, the risk that protection offered by our patents and self-evident applications may be challenged, invalidated or circumvented by our competitors, the risk that tender trends will continue and that the close by market by reason of our products will not be as gargantuan as expected, the chance that our products will not be skilled to penetrate one or more targeted markets, the risk that revenues will not be adequate to bread further development and clinical studies, the Company’s future initial needs, and its genius to obtain additional funding and other risks detailed from time to time in the Company’s filings with the Securities and Exchange Commission including the three-monthly report on Form 10-Q for the division ended December 31, 2007. Oculus Innovative Sciences disclaims any obligation to update these mail-looking statements.
Oculus, Microcyn and Dermacyn are trademarks or registered trademarks of Oculus Innovative Sciences, Inc. All other trademarks and service marks are the capital goods of their respective owners.
Oculus Innovative Sciences
Best Ever Personal Training Guide
Influence loss as is the custom sees a colossal uptake at the initiate of the New Year. This seems to be the time for individuals to re-assess their lives in myriads disparate sectors and load loss has appropriate for on of the largest well known zones to address.
With popular and international obesity levels on the increase which in turn is important to more health related illness such as category 2 diabetes at once is the time to act to screen your health.
Lack of time is frequently an area which citizens struggle to perceive as been at one’s fingertips to exercise. This identified obstruction is regularly closely followed by lack of confidence.
Lack of metre is time and again associated with not being masterful to fit in formerly to visit the gym. Lack of conviction can be traced requital to quondam attempts where you may display lost weight and then regained it every a particular of back again with an increment of a little bonus.
Whichever noted barrier you wait in your wavering be decided, take some speedily out and really grill it, and look for creative ways to overwhelmed them i.e. Forget the gym and proceeds a walk during your lunch break. Be without of confidence, go into by reviewing what your commendable at, we every individual of have something and try to produce your belief for this, reminisce over confidence is developed with even-sided paltry steps in the right avenue.
Set into any reserve shop, Google heaviness loss or pick up any celebrity munitions dump and you will present, hear or see hundreds possibly thousands of solutions.
To be expected solutions eventually and again include a balanced diet and fitness training programme.
Swimming is often chosen as a low crashing and gaiety tariff to agitate to advise with weight loss.
Swimming reduces the impact upon joints these as your knees, hips and back whilst at the same time allowing you to mark aggressive up a satisfactory level cardiovascular eligibility and muscle tone.
Aquarobics classes grant develop a very favoured off race of old swimming. A run-of-the-mill An Aquarobics class may be liked very much to an Aerobics kind on out landing without the impact on the joints and less talk into for footwork to remember. Aquarobics classes are often court at regional relief facilities or more up market healthfulness clubs.
When your comparing the diverse bias loss programmes close by you should look for the inclusion of three elementary sectors; healthy eating, exercise and behaviour modification. If a performance contains these three quintessential aspects your chances of success are individual, if as a matter of actual fact it no longer becomes a befall so great as your ready mentally.
You own it to yourself to pinpoint the right approach. With it longing become public increased one’s self faith and better selfhood-account not to mention having the body and punch levels you require.
Maragret Boldizsar is a ace familiar trainer who guides people emotionally squander bias with bright pilates programmes. Her customers experience tremendous weight waste.
4 million extra health workers needed worldwide
Authors of a public-vigorousness article in this week’s issue of THE LANCET are calling for urgent international deed to address the chronic lack of investment in human resources which is limiting the chance of tackling diseases such as HIV/AIDS, malaria, and TB.
The Lancet article is an executive summary of a fuller report about human resources investment and global health being published by Harvard University Press. The key premise of the article and full report is that no amount of improvements in the development of new treatments and relative reduction in financial costs of health services can make the required impact unless there is a renewed investment in human resources—health-care workers—to deliver health services in the areas where they are most needed, especially in sub-Saharan Africa.
The Joint Learning Initiative—a consortium of more than 100 health leaders—proposes that mobilisation and strengthening of human resources for health, neglected yet critical, is central to combating health crises in some of the world’s poorest countries and for building sustainable health systems in all countries.
Co-author of the study Lincoln Chen (Harvard University, USA) explains: “Nearly all countries are challenged by worker shortage, skill mix imbalance, maldistribution, negative work environment, and weak knowledge base. Especially in the poorest countries, the workforce is under assault by HIV/AIDS, out-migration, and inadequate investment. Effective country strategies should be backed by international reinforcement. Ultimately, the crisis in human resources is a shared problem requiring shared responsibility for cooperative action.�
The authors highlight how 4 million extra health workers worldwide are needed if the required health improvements and millennium goals are to be met by 2015. Human resources in sub-Saharan Africa are singled out as a top priority: the authors estimate that this region needs to triple its current human resources infrastructure by creating one million extra workers to deliver health services, most of them at the community level.
Dr. Chen comments: “It is impossible to underestimate the importance of a response to this call for action. At stake is nothing less than completing the unfinished agenda in health of the past century while addressing the historically unprecedented health challenges of this new century. Millions of people around the world are trapped in a vicious spiral of sickness and death. For them there is no tomorrow without action today. Yet, much can be done through the rapid mobilisation of the workforce, and wise investments today can build a stronger human infrastructure for sustainable health systems. What we do—or what we fail to do—will shape the course of global health for the entire 21st century.�
http://ww.thelancet.com
Flax In Diet Means Fewer Tumors
Immature research from South Dakota State University offers evidence that including flax in the diet may help prevent colorectal tumors or shut in tumors from growing as quickly when they do envisage.
Distinguished professor Chandradhar Dwivedi, head of SDSU’s Department of Pharmaceutical Sciences, directed the study by departmental graduate student researchers Ajay Bommareddy, Xiaoying Zhang and expert doctor of pharmacy student Dustin Schrader.
“The reflect on was conducted in a special purify of mice that develop knee-jerk intestinal tumors fitting to mutation in a gene,” Dwivedi said.
“This model is developed to investigate the effects of cancer anticipatory agents on genetically predisposed individuals,” he said.
“Results indicated that mice on diets supplemented with flaxseed carry to extremes and flaxseed lubricant had, on average, 45 percent fewer tumors in the young intestine and the colon compared to the repress group.”
The scientists published their enquire findings in February in the conjectural match-reviewed international journal Nutrition and Cancer.
“The results show that tumors in dietary flaxseed-treated groups, not counting being few, were also very small in take the measure of when compared with what we found in the other experimental diets,” Dwivedi said.
The study has momentous implications for human health, since colorectal cancer is the third-matchless cause of cancer deaths in the United States. Aware statistics from the American Cancer Society showed that in 2008, 108,070 new colon and 40,740 revitalized rectal cases were diagnosed in the Common States, while colorectal cancers caused 49,960 deaths.
Flaxseed contains a exalted percentage of alpha-linolenic acid, omega-3 fatty acid, and lignans, a group of chemical compounds found in plants that enactment as antioxidants.
The up to date SDSU study builds on past research carried out of the closet by Dwivedi’s lab at SDSU looking at the chemopreventive effects of dietary flaxseed fuel and flaxseed repast on colon tumor development.
“Dietary flaxseed unguent and meal are effective chemopreventive agents against colon and intestinal tumor development in experimental animal models,” Dwivedi said.
“Further studies are needed to secure the optimal amount of flaxseed that should be incorporated into human diets to be given an anti-tumor benefit and to explore the possible machinery of action by which flaxseed can serve prevent colon cancer.”
Other participating researchers included allied professor Radhey Kaushik, who has a joint assignation in SDSU’s Department of Veterinary Sciences and the Department of Biology and Microbiology; professor David Zeman, head of the Department of Veterinary Sciences; and professor Duane Matthees of the Department of Veterinary Sciences.
The research was supported in put asunder give up by North Dakota Oilseed Council.
Source: South Dakota State University
First-Tme Mothers At Increased Risk For Postpartum Mental Disorders
New mothers are at an increased chance because of mental disorders such as schizophrenia, depression and bipolar disorder in the 3 months following the birth of their opening child, according to a review in the December 6 issue of JAMA. The study also found that firstly-on one occasion fathers do not have an increased peril for mental disorders.
Postpartum depression is a serious mental health problem owing women and their families, with an estimated prevalence of upon 10 percent to 15 percent among mothers. Postpartum disorders can also include more severe mental disorders, with a prevalence of about 1 per 1,000 births, according to history news in the article. There is some intimation that a small interest of men experience postpartum depression, but the possible relationship between becoming a father and first onset of mental disorders has not been established.
Trine Munk-Olsen, M.Sc., of the University of Aarhus, Denmark and colleagues conducted a study to estimate the jeopardize of postpartum screwy disorders requiring hospital admission or outpatient contact for victory-time mothers and fathers up to 12 months after becoming a foster-parent. The researchers analyzed matter from Danish health and secular employment registers, which as this study included a gross of 2,357,942 Danish-born persons who were followed up from their 15th birthday or January 1973, whichever came later, until date of onslaught of the disorder in question, meeting of death, date of emigration from Denmark, or July 2005, whichever came first.
From 1973 to 2005, a total of 630,373 women and 547,431 men became parents for the first sometimes. A total of 1,171 women and 658 men were admitted with a batty mishmash to a psychiatric nursing home during the start with 12 months after parenthood, and the corresponding prevalence of severe mental disorders past the first 3 months after childbirth was 1.03 per 1,000 births championing mothers and 0.37 per 1,000 births into fathers. For first-time mothers, the from the word go weeks and months after the delivery were associated with an increased imperil of first conceding with any mental pandemonium, and the period from 10 to 19 days following the birth was associated with the highest danger (7.3 times increased risk) compared with women who had delineated birth 11 to 12 months previously. The increased risk of admission among mothers remained statistically significant through the first 3 months after childbirth regardless of lifetime of the natural. Risk because of mothers was also increased because psychiatric outpatient contacts through the first 3 months after childbirth, also with the highest risk occurring 10 to 19 days following the birth.
Unlike motherhood, fatherhood was not associated with any increased peril of hospital admission or outpatient contact. “This may indicate that the causes of postpartum nuts disorders are more strongly linked to an altered physiological process coordinated to pregnancy and childbirth than psychosocial aspects of motherhood.”
“Accurate estimates of the rates of and risk factors for postpartum indentation are highly portentous for the scientific and clinical understanding of perceptual and behavioral disorders during the postpartum age as wholly as for planning mental salubrity services because of childbearing women and their families,” the authors jot.
—————————-
Article adapted by Medical News Today from unusual induce release.
—————————-
(JAMA. 2006;296:2582-2589.)
This study was supported by the Stanley Medical Research Institute, Chevy Run after, Md. Psychiatric epidemiological examine at the National Concentrate for Register-Based Research is in part funded through a collaborative concurrence with the Cluster for Basic Psychiatric Research, Psychiatric Sickbay, Aarhus, Denmark. Choose visualize the article because of additional report, including other authors, initiator contributions and affiliations, financial disclosures, funding and vouch for, etc.
Editorial: Postpartum Depression - A Major Viewable Salubriousness Difficulty
In an accompanying leading article, Katherine L. Wisner, M.D., M.S., of the University of Pittsburgh Medical Center, and colleagues comment on the findings concerning postpartum downheartedness.
“These collective data [Munk-Olsen et al and other studies] draw attention to the importance of recognizing childbearing as a mighty health factor in the compulsion movement of women. Childbearing influences the indubitably of any disease state and acts as a biopsychosocial factor that may facilitate new episodes of bug. The data also provide data to identify and support universal screening proper for postpartum well-disposed episodes. The studies converge on the dead for now frame of pre-eminent imperil for both hospitalization and outpatient contacts as the first 3 months postpartum, particularly in primiparae [first birth], independent of considerations of diagnosis,” they write. “Therefore, screening should be implemented as at daybreak as 2 weeks after delivery and no later than 12 weeks postpartum to single out episodes of major mood disorder and other mental illnesses.”
“Effective treatments for these episodes exist. Sudden implementation of treatment is careful because mood episodes can be lengthy and psychosocial sequelae increase with duration. Caring dent exacts a heavy toll on women’s functioning and the health and well-being of their children. … Mental health is crucial to a mother’s perspicacity to function optimally, enjoy relationships, modify also in behalf of the infant’s birth, and cope with the stresses and appreciate the joys of parenthood.”
(JAMA. 2006;296:2616-2618.)
Please see the editorial for the duration of additional information, including other authors, litterateur contributions and affiliations, financial disclosures, funding and support, etc.
Contact: Trine Munk-Olsen
JAMA and Archives Journals